Stock Events

Stock Events

Eisai 

$8.07
44
+$0.27+3.46% Today

Statistics

Day High
7.8
Day Low
7.65
52W High
9.22
52W Low
5.94
Volume
5,325
Avg. Volume
80,698
Mkt Cap
2.35B
P/E Ratio
27.11
Dividend Yield
3.43%
Dividend
0.28

Upcoming

12
JUN
Dividend Payment
Estimated
 
29
SEP
Dividend Ex
Estimated
 
3
DEC
Dividend Payment
Estimated
 
30
MAR 27
Dividend Ex
Estimated
 
11
JUN 27
Dividend Payment
Estimated
 

Dividends

3.43%Dividend Yield
Dec 25
$0.13
Jun 25
$0.14
Dec 24
$0.13
Jun 24
$0.13
Dec 23
$0.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-1.03%
1Y Growth
N/A

Earnings

20MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.02
0.19
0.36
0.53
Expected EPS
0.08379756126
Actual EPS
N/A

Financials

5.88%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
10.65BRevenue
625.87MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ESAIY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen collaborates with Eisai on Alzheimer's treatments, but also competes in broader neurological drug markets.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes in the development of drugs for various conditions, including Alzheimer's, which is a key area for Eisai.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly is a direct competitor in the Alzheimer's drug market, particularly with its advancements in treatments similar to Eisai's offerings.
Merck
MRK
Mkt Cap214.76B
Merck competes in the pharmaceutical sector, including areas like cancer and Alzheimer's treatments, overlapping with Eisai's research and drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes across a broad range of healthcare sectors, including areas where Eisai is active such as neuroscience.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in neuroscience and oncology, directly challenging Eisai's market share in these therapeutic areas.
Novartis
NVS
Mkt Cap237.61B
Novartis competes in many of the same therapeutic areas as Eisai, including neuroscience and oncology, with a strong focus on innovation and R&D.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca competes in the oncology sector, among others, where Eisai also has a significant presence and investment.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with Eisai in areas such as oncology and neurological conditions, with both companies seeking to expand their portfolios in these domains.

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Haruo Naito
Employees
11067
Country
US
ISIN
US28258A1079

Listings

MX
MX
4523N.MX
F
DE
EIIA.F
OTC Link
US
ESALF
TSE
JP
4523.TSE

0 Comments

Share your thoughts

FAQ

What is Eisai stock price today?▼
The current price of ESAIY is $8.07 USD — it has increased by +3.46% in the past 24 hours. Watch Eisai stock price performance more closely on the chart.
What is Eisai stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eisai stocks are traded under the ticker ESAIY.
Is Eisai stock price growing?▼
ESAIY stock has risen by +2.36% compared to the previous week, the month change is a -6.02% fall, over the last year Eisai has showed a +14.87% increase.
What is Eisai market cap?▼
Today Eisai has the market capitalization of 2.35B
When is the next Eisai earnings date?▼
Eisai is going to release the next earnings report on May 20, 2026.
What were Eisai earnings last quarter?▼
ESAIY earnings for the last quarter are 0.39 USD per share, whereas the estimation was 0.47 USD resulting in a -17.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Eisai revenue for the last year?▼
Eisai revenue for the last year amounts to 10.65B USD.
What is Eisai net income for the last year?▼
ESAIY net income for the last year is 625.87M USD.
Does Eisai pay dividends?▼
Yes, ESAIY dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 3.43%.
How many employees does Eisai have?▼
As of April 01, 2026, the company has 11,067 employees.
In which sector is Eisai located?▼
Eisai operates in the Health Care sector.
When did Eisai complete a stock split?▼
Eisai has not had any recent stock splits.
Where is Eisai headquartered?▼
Eisai is headquartered in Tokyo, US.